The Incidence and Management of Cutaneous Adverse Events of the Epidermal Growth Factor Receptor Inhibitors

    Witold Owczarek, Monika Słowińska, Aleksandra Lesiak … Rafał Czajkowski
    Studysummary This review discusses the adverse skin effects of EGFR inhibitors used in cancer treatment, exploring their mechanisms and offering strategies for prevention and management, but reports no new experimental findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on termedia.pl →
    Discuss this study in the Community →

    Research cited in this study 6

    1. Cutaneous Adverse Effects of Targeted Therapies Journal of the American Academy of Dermatology · 2015
    2. Cutaneous Adverse Effects of Targeted Therapies Journal of the American Academy of Dermatology · 2015
    3. Cutaneous Reactions to Chemotherapeutic Drugs and Targeted Therapy for Cancer Journal of the American Academy of Dermatology · 2014
    4. Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management Dermatology research and practice · 2014
    5. Dermatologic Adverse Events Associated With Afatinib: An Oral ErbB Family Blocker Expert Review of Anticancer Therapy · 2013
    6. Classification and Management of Skin, Hair, Nail, and Mucosal Side Effects of Epidermal Growth Factor Receptor Inhibitors European journal of cancer · 2007